Morbidity and mortality are markedly elevated in chronic kidney disease (CKD) patients as
consequence of cardiovascular risk factors clustering. Non-traditional risk factors such as …

Introduction Pulmonary hypertension (PH) in the setting of end-stage renal disease (ESRD)
has important prognostic and therapeutic consequences. We estimated the prevalence of …

Background Hemodialysis patients are at an increased risk of cardiovascular (CV) morbidity
and mortality. Pulmonary hypertension (PH) has been recently reported as a new entity and …

Pulmonary hypertension in end-stage renal disease patients is associated with significantly
increased morbidity and mortality. The prevalence of pulmonary hypertension in dialysis …

Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid
conditions. Based on these associations, PH is classified into 5 groups, considering …

Background. Management of pediatric pulmonary hypertension (PH) remains challenging.
We have assessed a panel of circulating proteins in children with PH to investigate their …

Patients with advanced chronic kidney disease are at a high risk of cardiovascular events.
Patients with end-stage renal disease have a particularly high morbidity and mortality, in part …

The prevalence of pulmonary hypertension (PH) in chronic kidney disease (CKD) in Indian
patients has been evaluated in this study. In addition, association of PH with CKD etiology …

Background The pathogenesis of pulmonary hypertension (PH) in hemodialysis is still
unclear. The aim of this study was to identify the risk factors associated with the presence of …

Aim: C‐reactive protein (CRP) level predicts future cardiovascular events in patients on
haemodialysis (HD). Advanced glycation end products (AGE) play a role in cardiovascular …